Federal Register / Vol. 62, No. 249 / Tuesday, December 30, 1997 / Notices 67883

with provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and section 10(d) of Public Law 92–463,

for the review, discussion and

evaluation of individual grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Ms. Kathy Kaplan, Public Affairs

Specialist, NCRR, National Institutes of

Health, One Rockledge Centre, Room

5146, 6705 Rockledge Drive, MSC 7965,

Bethesda, Maryland 20892–7965, 301–

435–0888, will provide summaries of

meetings and rosters of committee

members. Other information pertaining

to the meetings can be obtained from the

Scientific Review Administrator

indicated. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact the Scientific Review

Administrator listed below, in advance

of the meeting.

Name of Committee: National Center for

Research Resources Initial Review Group—

Research Centers in Minority Institutions

Review Committee.

Date of Meeting: February 9, 1998.

Place of Meeting: Residence Inn,

Montgomery I Room, 7335 Wisconsin

Avenue, Bethesda, MD 20814, 301–718–

0200.

Open: February 9, 8:30 a.m.–10:30 a.m.

Closed: February 9, 10:30 a.m.—Until

Adjournment.

Scientific Review Administrator: Dr. John

Lymangrover, National Institutes of Health,

One Rockledge Centre, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965; Telephone: 301–435–0820.

Name of Committee: National Center for

Research Resources Initial Review Group—

General Clinical Research Centers Review

Committee.

Date of Meeting: February 10–13, 1998.

Place of Meeting: Hyatt Regency Bethesda,

Fellin’s Bar Conference Room, One Bethesda

Metro Center, Bethesda, MD 20814, 301–357–

6406.

Closed: February 10—8 a.m.—Until

Adjournment.

Scientific Review Administrator: Dr.

Charles Hollingsworth, National Institutes of

Health, One Rockledge Centre, Room 6018,

6705 Rockledge Drive, MSC 7965, Bethesda,

MD 20892–7965; Telephone: 301–435–0806.

Name of Committee: National Center for

Research Resources Initial Review Group—

Comparative Medicine Review Committee.

Date of Meeting: February 24–25, 1998.

Place of Meeting: Holiday Inn Bethesda,

Delaware Room, 8120 Wisconsin Avenue,

Bethesda, MD 20814, 301–652–2000.

Open: February 24, 8 a.m.–9:30 a.m.

Closed: February 24, 9:30 a.m.—Until

Adjournment.

Scientific Review Administrator: Dr.

Raymond O’Neill, National Institutes of

Health, One Rockledge Centre, Room 6018,

6705 Rockledge Drive, MSC 7965, Bethesda,

MD 20892–7965; Telephone: 301–435–0820.

Name of Committee: Scientific and

Technical Review Board on Biomedical and

Behavioral Research Facilities.

Date of Meeting: February 25, 1998.

Place of Meeting: The Bethesda Ramada,

Ambassador One Room, 8400 Wisconsin

Avenue, Bethesda, MD 20814, 301–654–

1000.

Closed: February 25, 8 a.m.—Until

Adjournment.

Scientific Review Administrator: Dr. D.G.

Patel, National Institutes of Health, One

Rockledge Centre, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965; Telephone: 301–435–0824.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, Laboratory Animal

Sciences and Primate Research; 93.333,

Clinical Research; 93.389, Research Centers

in Minority Institutions; 93.167, Research

Facilities Improvement Program; 93.214

Extramural Research Facilities Construction

Projects, National Institutes of Health)

Dated: December 22, 1997.

LaVeen M. Ponds,

Program Analyst.

[FR Doc. 97–33942 Filed 12–29–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

Microbiology and Infectious Diseases

Research Committee

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the Microbiology and Infectious

Diseases Research Committee, National

Institute of Allergy and Infectious

Diseases, on February 11–13, 1998 at the

Holiday Inn Chevy Chase, Mayfair

Room, 5520 Wisconsin Avenue,

Bethesda, Maryland.

The meeting will be open to the

public from 8 a.m. to 9 a.m. on February

11, to discuss administrative details

relating to committee business and

program review, and for a report from

the Acting Director, Division of

Extramural Activities, which will

include a discussion of budgetary

matters. Attendance by the public will

be limited to space available.

In accordance with the provisions set

forth in sections 552b(c)(4) and

552b(c)6), Title 5, U.S.C. and section

10(d) of Public Law 92–463, the meeting

will be closed to the public for the

review, discussion, and evaluation of

individual grant applications and

contract proposals from 9 a.m. until

recess on February 11, from 9 a.m. until

recess on February 12, and from 9 a.m.

until adjournment on February 13.

These applications, proposals and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material and

personal information concerning

individuals associated with the

applications and proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

Ms. Claudia Goad, Committee

Management Officer, National Institute

of Allergy and Infectious Diseases, Solar

Building, Room 3C26, National

Institutes of Health, Bethesda,

Maryland, 301–496–7601, will provide a

summary of the meeting and a roster of

committee members upon request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Goad in advance of the

meeting.

Dr. Gary Madonna, Scientific Review

Administrator, Microbiology and

Infectious Diseases Research Committee,

NIAID, NIH, Solar Building, Room

4C21, Rockville, Maryland 20892,

telephone 301–496–3528, will provide

substantive program information.

(Catalog of Federal Domestic Assistance

Program No. 93.856, Microbiology and

Infectious Diseases Research, National

Institutes of Health)

Dated: December 22, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–33940 Filed 12–29–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Special Emphasis Panel

meeting.

Purpose/Agenda: To review and evaluate

contract proposals.

Name of Committee: NIDA Special

Emphasis Panel (SBIR Project—‘‘Drug Supply

Services Support’’).

Date: January 15, 1998.

Time: 9:00 a.m.